Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
07/2003
07/31/2003US20030143278 Vaginal delivery of drugs
07/31/2003US20030143275 Cosmetic and/or dermatological composition containing at least one oxidation-sensitive hydrophilic active principle and at least one N-vinylimidazole polymer or copolymer
07/31/2003US20030143272 Pharmaceutical tablet and process for making thereof
07/31/2003US20030143271 For therapy and prophylaxis of cyclooxygenase-2 mediated disorder and for providing cardioprotection
07/31/2003US20030143269 Tamper-resistant oral opioid agonist formulations
07/31/2003US20030143265 Administering riboflavin or derivatives
07/31/2003US20030143250 Pharmaceutical compositions comprising cyclosporins
07/31/2003US20030143232 Incubating survivin and p34cdc2-cyclin B1 kinase complex in presence of an agent; determining whether agent modulates phosphorylation of survivin by p34cdc2-cyclin B1 kinase complex, identifying an agent which modulates phosphorylation
07/31/2003US20030143230 Combination of an IL-1/18 inhibitor with a TNF inhibitor for the treatment of inflammation
07/31/2003US20030143223 Modulating the activity of one or more elements in the complement/lipid pathway
07/31/2003US20030143216 For therapy of fungal infections; for detecting chitin, binding chitin
07/31/2003US20030143209 For gene therapy of cancers or cardiovascular conditions
07/31/2003US20030143207 Remodeling of tissues and organ
07/31/2003US20030143197 Administering to the animal omega interferon (IFN) at a dosage and activity for the disease state treated sufficient to induce a therapeutic response in the animal
07/31/2003US20030143185 Polymer conjugates of protein kinase C inhibitors
07/31/2003US20030143183 Combined use of a GLP-1 compound and another drug for treating dyslipidemia
07/31/2003US20030143166 Aqueous dispersion of water-insoluble organic UV filter substances
07/31/2003US20030143165 Regularly applying a topical formulation to the skin of patient, formulation containing a pharmaceutically effective amount of a non- steroidal anti-inflammatory drug
07/31/2003US20030143163 For therapy of respiratory disorders; aerosol formulations of use for the administration of medicaments by inhalation
07/31/2003US20030143161 Medicine, carrier for medicine, method of producing medicine, and method of tumor treatment
07/31/2003DE20305898U1 Pharmaceutical compositions include vitamins and optionally trace elements to enhance the therapeutic effect and/or reduce the side effects of drugs
07/31/2003CA2840490A1 Polyalkylene glycol with moiety for conjugating biologically active compounds
07/31/2003CA2753899A1 Polyalkylene glycol with moiety for conjugating biologically active compounds
07/31/2003CA2514088A1 Use of cholinesterase antagonists to treat insulin resistance
07/31/2003CA2514081A1 Use of phosphodiesterase antagonists to treat insulin resistance
07/31/2003CA2476565A1 Methods and compositions for reducing the development of drug tolerance and/or physical dependence
07/31/2003CA2474201A1 Statins (hmg-coa reductase inhibitors) as a novel type of immunomodulator, immunsuppressor and anti-inflammatory agent
07/31/2003CA2474077A1 Methods for treatment of multiple sclerosis with statins
07/31/2003CA2473927A1 Methods and compositions for treating polycystic ovary syndrome
07/31/2003CA2473924A1 Systems and methods for photodynamic therapy
07/31/2003CA2473829A1 Use of tgf-.beta. antagonists to treat or to prevent chronic transplant rejection
07/31/2003CA2473748A1 Novel targeted compositions for diagnostic and therapeutic use
07/31/2003CA2473740A1 Methods of treating conditions associated with an edg receptor
07/31/2003CA2473721A1 Use of benzothiazepines having activity as inhibitors of ileal bile acid transport for reducing cholesterololemia
07/31/2003CA2473707A1 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
07/31/2003CA2473697A1 Compositions for pulmonary administration
07/31/2003CA2473536A1 Pharmaceutical composition and method for treating disorders of the central nervous system
07/31/2003CA2473490A1 Peptide-carrying bodies for immune response
07/31/2003CA2473474A1 Alteration of rab38 function to modulate mammalian pigmentation
07/31/2003CA2473395A1 Phospholipid bodies and use thereof in medical treatment
07/31/2003CA2473392A1 5-ht3 receptor antagonists and methods of use
07/31/2003CA2473254A1 Combination therapy for the treatment of bacterial infections
07/31/2003CA2473040A1 A weight management system for obese animals
07/31/2003CA2473036A1 Melanocortin receptor agonists
07/31/2003CA2472682A1 Treating stress response with chemokine receptor ccr5 modulators
07/31/2003CA2472578A1 Anti-cancer combination and use thereof
07/31/2003CA2472367A1 N-(4-substituted phenyl)-anthranilic acid hydroxamate esters
07/31/2003CA2472240A1 Tibolone in the treatment of complaints associated with the administration of drugs which prevent the synthesis of endogenous estrogen
07/31/2003CA2471740A1 Pharmaceutically acceptable phosphate-glycerol carrying bodies
07/31/2003CA2470185A1 Use of alkylphosphocholines in the prevention of protozoal diseases
07/31/2003CA2466266A1 Novel substituted alkane compounds and uses thereof
07/30/2003EP1331004A2 Aminotetralin Derivative for the Therapy of Cardiovascular Diseases
07/30/2003EP1330548A2 Methods of diagnosing, preventing and treating neurological disorders and neuronal injuries
07/30/2003EP1330543A2 Nucleic acid sequences differentially expressed in cancer tissue
07/30/2003EP1330538A2 Cd36 as a heat shock protein receptor and uses thereof
07/30/2003EP1330537A1 Membrane fractions of 1,2-sn-diacylglycerol-enriched cells
07/30/2003EP1330535A2 Kini-3 motor protein and methods for its use
07/30/2003EP1330528A2 Regulation of human serine-threonine protein kinase
07/30/2003EP1330522A1 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
07/30/2003EP1330521A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
07/30/2003EP1330470A1 Glutathione conjugates with distamycin derivatives having antitumor activity
07/30/2003EP1330463A2 Beta-substituted beta-aminoethyl phosphonates
07/30/2003EP1330459A2 Triptolide analogs for the treatment of autoimmune and inflammatory disorders
07/30/2003EP1330448A2 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat vcam-1 mediated disorders
07/30/2003EP1330426A1 Selective maxi-k- potassium channel openers functional under conditions of high intracellular calcium concentration, methods and uses thereof
07/30/2003EP1330293A2 Controlled release composition comprising lactic acid polymer and hydroxynaphthoic acid, and method of producing the same
07/30/2003EP1330271A2 Use of transcription factors for treating inflammation and other diseases
07/30/2003EP1330268A1 Targeted therapeutic agents
07/30/2003EP1330267A1 Olfactory neuron cultures and method of making and using the same
07/30/2003EP1330264A2 Vaccine for treating allergy
07/30/2003EP1330260A1 Use of il-1 inhibitors and tnf antagonists, partially in combination with recombinant erythropoietins, for the treatment of anemia
07/30/2003EP1330257A1 Gnrh analogues for treatment of urinary incontinence
07/30/2003EP1330254A2 Treatment of cancers by aplidine in conjunction with a myoprotector
07/30/2003EP1330251A1 Combination therapy for the treatment of estrogen-sensitive disease
07/30/2003EP1330243A2 Use of carp inhibitors for the treatment of heart diseases
07/30/2003EP1330242A2 Antiproliferative colchicine compositions and uses thereof
07/30/2003EP1330240A2 Use of 20-hete synthesizing enzyme inhibitors as therapy for cerebral vascular diseases
07/30/2003EP1330238A1 Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor
07/30/2003EP1330226A2 Method for producing purified hematinic iron-saccharidic complex and product produced
07/30/2003EP1330221A2 Medical compositions, dressings and methods for treating microbial infections of skin lesions
07/30/2003EP1178832B1 Novel medicament compositions, based on tiotropium bromide and salmeterol
07/30/2003EP1056442B1 Antibiotics in dry dosage forms for the treatment of shallow ulcers of the oral mucosa
07/30/2003EP0983074B1 Non-myeloablative tolerogenic treatment
07/30/2003EP0975362B1 Pharmaceutical or food composition for treating pathologies related to graft versus host, allergic or autoimmune reaction
07/30/2003EP0966286B1 Attenuation of opioid tolerance by inhibiting inducible nitric oxide synthase pathways in the treatment of pain
07/30/2003EP0942780B1 Coated particles, methods of making and using
07/30/2003EP0910400B1 Therapies for chronic renal failure
07/30/2003EP0910376B1 Use of clotrimazole and related compounds in the treatment of diarrhea
07/30/2003EP0832198B1 Oxygen activatable formulations for disinfection or sterilization
07/30/2003EP0814801B1 Use of a pyruvate dehydrogenase activator for the treatment of ischaemia in limbs
07/30/2003EP0710105B1 Synergistic anthelmintic compositions against fasciola hepatica and other fasciola species
07/30/2003CN1433480A Feeding assay for identifying nematicidal compounds
07/30/2003CN1433477A Method of achieving persistent transgene expression
07/30/2003CN1433469A Therapeutically useful synthetic oligonucleotides
07/30/2003CN1433466A MASP-3, complement-fixing enzyme, and uses for it
07/30/2003CN1433417A Pyridopyrimidinone derivatives for treatment of neurodegenerative disease
07/30/2003CN1433416A N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl] carboxamideinhibitors of cyclin dependent kinases
07/30/2003CN1433415A N-[5-[[[5-alkyl-2-oxazlyl]methyl]thio]-2-thiazolyl] carboxamide inhibitors of cyclin dependent kinases
07/30/2003CN1433408A Aminothiazole inhibitors of cyslin dependent kinases
07/30/2003CN1433325A Techniques and compositions for treating cardiovascular disease by in vivo gene delivery
1 ... 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 ... 1151